For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Dapsone Gel 7.5% | Dapsone gel 7.5% to be applied to truncal acne once daily for 16 weeks. Dapsone 7.5 % gel: Dapsone gel 7.5% applied once daily to truncal acne | 0 | None | 0 | 20 | 3 | 20 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| stye, right eye | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| sunburn arms/chest/back | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| infected abrasions of legs | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| gum graft surgery | SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | None | View |